Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Use of neutrophil gelatinase-associated lipocalin (NGAL) in CF.

Munro C, Ranganathan S, Coulthard K, Quinlan C.

J Cyst Fibros. 2015 Jan;14(1):154. doi: 10.1016/j.jcf.2014.06.010. Epub 2014 Jul 10. No abstract available.

2.

A feasibility study of expert patient and community mental health team led bipolar psychoeducation groups: implementing an evidence based practice.

Coulthard K, Patel D, Brizzolara C, Morriss R, Watson S.

BMC Psychiatry. 2013 Nov 11;13:301. doi: 10.1186/1471-244X-13-301.

3.

Drug approval processes in Australian Paediatric Hospitals.

Sinha YK, Craig JC, Barclay P, Taitz J, South M, Coulthard K, Pearson C, Erickson S, Brien JE.

Arch Dis Child. 2010 Sep;95(9):739-44. doi: 10.1136/adc.2009.177063. Epub 2010 Jun 28.

PMID:
20584852
4.

What is the best method for measuring renal function in adults and children with cystic fibrosis?

Soulsby N, Greville H, Coulthard K, Doecke C.

J Cyst Fibros. 2010 Mar;9(2):124-9. doi: 10.1016/j.jcf.2009.12.002. Epub 2010 Feb 4.

5.

Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models.

Dudhani RV, Turnidge JD, Coulthard K, Milne RW, Rayner CR, Li J, Nation RL.

Antimicrob Agents Chemother. 2010 Mar;54(3):1117-24. doi: 10.1128/AAC.01114-09. Epub 2009 Dec 22.

6.

Renal dysfunction in cystic fibrosis: is there cause for concern?

Soulsby N, Greville H, Coulthard K, Doecke C.

Pediatr Pulmonol. 2009 Oct;44(10):947-53. doi: 10.1002/ppul.21086. Review.

PMID:
19728391
7.

Renal disposition of colistin in the isolated perfused rat kidney.

Ma Z, Wang J, Nation RL, Li J, Turnidge JD, Coulthard K, Milne RW.

Antimicrob Agents Chemother. 2009 Jul;53(7):2857-64. doi: 10.1128/AAC.00030-09. Epub 2009 Apr 20.

8.

Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients.

Wallace SJ, Li J, Rayner CR, Coulthard K, Nation RL.

Antimicrob Agents Chemother. 2008 Sep;52(9):3047-51. doi: 10.1128/AAC.00103-08. Epub 2008 Jul 7.

9.

Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model.

Bergen PJ, Li J, Nation RL, Turnidge JD, Coulthard K, Milne RW.

J Antimicrob Chemother. 2008 Mar;61(3):636-42. doi: 10.1093/jac/dkm511. Epub 2008 Jan 28.

PMID:
18227094
10.

Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimens.

Wallace SJ, Li J, Nation RL, Rayner CR, Taylor D, Middleton D, Milne RW, Coulthard K, Turnidge JD.

Antimicrob Agents Chemother. 2008 Mar;52(3):1159-61. doi: 10.1128/AAC.01101-07. Epub 2008 Jan 7.

11.

Community use of intranasal midazolam for managing prolonged seizures.

Kyrkou M, Harbord M, Kyrkou N, Kay D, Coulthard K.

J Intellect Dev Disabil. 2006 Sep;31(3):131-8.

PMID:
16954090
12.

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.

Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL.

Lancet Infect Dis. 2006 Sep;6(9):589-601. Review.

PMID:
16931410
13.

Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations.

Coulthard KP, Peckham DG, Conway SP, Smith CA, Bell J, Turnidge J.

J Cyst Fibros. 2007 Apr;6(2):125-30. Epub 2006 Jul 7.

14.

Re: Antibiotic renal failure and cystic fibrosis.

Coulthard K, Smith C, Martin J.

J Paediatr Child Health. 2006 Jan-Feb;42(1-2):72-3; author reply 73. No abstract available.

PMID:
16487396
15.

Determination of tobramycin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis.

Madsen V, Lind A, Rasmussen M, Coulthard K.

J Cyst Fibros. 2004 Dec;3(4):249-51. Epub 2004 Oct 27.

16.

Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.

Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K.

Int J Antimicrob Agents. 2005 Jan;25(1):11-25. Review.

PMID:
15620821
17.

Use of intranasal midazolam to treat acute seizures in paediatric community settings.

Harbord MG, Kyrkou NE, Kyrkou MR, Kay D, Coulthard KP.

J Paediatr Child Health. 2004 Sep-Oct;40(9-10):556-8.

PMID:
15367152
18.

Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate.

Li J, Milne RW, Nation RL, Turnidge JD, Smeaton TC, Coulthard K.

J Antimicrob Chemother. 2004 May;53(5):837-40. Epub 2004 Mar 24.

PMID:
15044428
19.

Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis.

Li J, Coulthard K, Milne R, Nation RL, Conway S, Peckham D, Etherington C, Turnidge J.

J Antimicrob Chemother. 2003 Dec;52(6):987-92. Epub 2003 Oct 29.

PMID:
14585859
20.

Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration.

Li J, Milne RW, Nation RL, Turnidge JD, Smeaton TC, Coulthard K.

Antimicrob Agents Chemother. 2003 May;47(5):1766-70.

21.

Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography.

Li J, Milne RW, Nation RL, Turnidge JD, Coulthard K.

Antimicrob Agents Chemother. 2003 Apr;47(4):1364-70.

22.

Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography.

Li J, Milne RW, Nation RL, Turnidge JD, Coulthard K, Valentine J.

Antimicrob Agents Chemother. 2002 Oct;46(10):3304-7.

23.
24.

Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study.

Master V, Roberts GW, Coulthard KP, Baghurst PA, Martin A, Roberts ME, Onishko CR, Martin AJ, Linke RJ, Holmes M, Jarvinen A, Kennedy D, Colebatch KA, Hansman D, Parsons DW.

Pediatr Pulmonol. 2001 May;31(5):367-76.

PMID:
11340683
25.
26.

Tropisetron plus dexamethasone is more effective than tropisetron alone for the prevention of postoperative nausea and vomiting in children undergoing tonsillectomy.

Holt R, Rask P, Coulthard KP, Sinclair M, Roberts G, Van Der Walt J, MacKenzie V, Rasmussen M.

Paediatr Anaesth. 2000;10(2):181-8.

PMID:
10736082
27.

Tropisetron reduces postoperative vomiting in children undergoing tonsillectomy.

Jensen AB, Christiansen DB, Coulthard K, Wilkins A, Roberts G, Walt JH, Rasmussen M.

Paediatr Anaesth. 2000;10(1):69-75.

PMID:
10632913
28.

Repeated dose inhaled budesonide versus placebo in the treatment of croup.

Roberts GW, Master VV, Staugas RE, Raftos JV, Parsons DW, Coulthard KP, Martin AJ.

J Paediatr Child Health. 1999 Apr;35(2):170-4.

PMID:
10365355
29.

Relative bioavailability and plasma paracetamol profiles of Panadol suppositories in children.

Coulthard KP, Nielson HW, Schroder M, Covino A, Matthews NT, Murray RS, Van Der Walt JH.

J Paediatr Child Health. 1998 Oct;34(5):425-31.

PMID:
9767504
30.

Paracetamol for fever in children.

Frank OR, Coulthard KP.

Aust Fam Physician. 1988 Sep;17(9):771. No abstract available.

PMID:
3240191
31.

Lack of effect of erythromycin on the pharmacokinetics of single oral doses of phenytoin.

Milne RW, Coulthard K, Nation RL, Penna AC, Roberts G, Sansom LN.

Br J Clin Pharmacol. 1988 Sep;26(3):330-3.

32.

Convulsions after miconazole overdose.

Coulthard K, Martin J, Matthews N.

Med J Aust. 1987 Jan 5;146(1):57-8. No abstract available.

PMID:
3796399
33.

Counter-disaster manual.

Challen RG, Davis JL, Bice EL, Coulthard KP.

Med J Aust. 1985 Sep 16;143(6):267-8. No abstract available.

PMID:
4033522
34.

Circadian variation in the absorption of three sustained release theophylline products in asthmatic children and the effect of food on absorption of Somophyllin-CRT.

Birkett DJ, Coulthard KP, Lines D, Grgurinovich N.

Br J Clin Pract Suppl. 1984;35:17-23. No abstract available.

PMID:
6433954
36.

Bioavailability and diurnal variation in absorption of sustained release theophylline in asthmatic children.

Coulthard KP, Birkett DJ, Lines DR, Grgurinovich N, Grygiel JJ.

Eur J Clin Pharmacol. 1983;25(5):667-72.

PMID:
6686557

Supplemental Content

Loading ...
Support Center